Depreciation, Depletion and Amortization of Orchard Therapeutics plc from 31 Dec 2020 to 31 Mar 2023

Taxonomy & unit: us-gaap: USD
Description: The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary: Orchard Therapeutics plc quarterly and annual Depreciation, Depletion and Amortization in USD history and change rate from 31 Dec 2020 to 31 Mar 2023.
Orchard Therapeutics plc Depreciation, Depletion and Amortization for the quarter ending 31 Mar 2023 was $643,000, a 9.3% decline year-over-year.
Orchard Therapeutics plc annual Depreciation, Depletion and Amortization for 2022 was $2,741,000, a 18% increase from 2021.
Orchard Therapeutics plc annual Depreciation, Depletion and Amortization for 2021 was $2,327,000, a 16% increase from 2020.
Source SEC data: View on sec.gov

Depreciation, Depletion and Amortization, Quarterly (USD)

Depreciation, Depletion and Amortization, YoY Quarterly Change (%)

Depreciation, Depletion and Amortization, Annual (USD)

Depreciation, Depletion and Amortization, YoY Annual Change (%)

Orchard Therapeutics plc Quarterly Depreciation, Depletion and Amortization (USD)

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
Q1 2023	$643,000	-$66,000	-9.3%	01 Jan 2023	31 Mar 2023	10-Q	15 May 2023	2023	Q1
Q1 2022	$709,000	+$214,000	+43%	01 Jan 2022	31 Mar 2022	10-Q	15 May 2023	2023	Q1
Q1 2021	$495,000			01 Jan 2021	31 Mar 2021	10-Q	12 May 2022	2022	Q1

Period	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed	Fiscal Year	Fiscal Period
2022	$2,741,000	+$414,000	+18%	01 Jan 2022	31 Dec 2022	10-K	14 Mar 2023	2022	FY
2021	$2,327,000	+$323,000	+16%	01 Jan 2021	31 Dec 2021	10-K	14 Mar 2023	2022	FY
2020	$2,004,000			01 Jan 2020	31 Dec 2020	10-K	30 Mar 2022	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.